These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8209380)

  • 1. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.
    Kelce WR; Monosson E; Gamcsik MP; Laws SC; Gray LE
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):276-85. PubMed ID: 8209380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinclozolin does not alter progesterone receptor (PR) function in vivo despite inhibition of PR binding by its metabolites in vitro.
    Laws SC; Carey SA; Kelce WR; Cooper RL; Gray LE
    Toxicology; 1996 Sep; 112(3):173-82. PubMed ID: 8845038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat.
    Monosson E; Kelce WR; Lambright C; Ostby J; Gray LE
    Toxicol Ind Health; 1999; 15(1-2):65-79. PubMed ID: 10188192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.
    Wong C; Kelce WR; Sar M; Wilson EM
    J Biol Chem; 1995 Aug; 270(34):19998-20003. PubMed ID: 7650017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat.
    Gray LE; Ostby JS; Kelce WR
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):46-52. PubMed ID: 7974495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro.
    Ostby J; Kelce WR; Lambright C; Wolf CJ; Mann P; Gray LE
    Toxicol Ind Health; 1999; 15(1-2):80-93. PubMed ID: 10188193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat.
    Gray LE; Ostby J; Monosson E; Kelce WR
    Toxicol Ind Health; 1999; 15(1-2):48-64. PubMed ID: 10188191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative and antagonistic effects of a mixture of the antiandrogens vinclozolin and iprodione in the pubertal male rat.
    Blystone CR; Lambright CS; Cardon MC; Furr J; Rider CV; Hartig PC; Wilson VS; Gray LE
    Toxicol Sci; 2009 Sep; 111(1):179-88. PubMed ID: 19564212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor profiling of vinclozolin and its primary metabolites.
    Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin.
    Wolf CJ; LeBlanc GA; Ostby JS; Gray LE
    Toxicol Sci; 2000 May; 55(1):152-61. PubMed ID: 10788570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of the anti-androgenic fungicide vinclozolin by rat liver microsomes.
    Sierra-Santoyo A; Angeles-Soto E; de Lourdes López-González M; Harrison RA; Hughes MF
    Arch Toxicol; 2012 Mar; 86(3):413-21. PubMed ID: 22002493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function.
    Uzumcu M; Suzuki H; Skinner MK
    Reprod Toxicol; 2004; 18(6):765-74. PubMed ID: 15279874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic exposure to the fungicide vinclozolin causes virilization of females and alteration of progesterone receptor expression in vivo: an experimental study in mice.
    Buckley J; Willingham E; Agras K; Baskin LS
    Environ Health; 2006 Feb; 5():4. PubMed ID: 16504050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and postnatal oral toxicity of vinclozolin in Wistar and Long-Evans rats.
    Hellwig J; van Ravenzwaay B; Mayer M; Gembardt C
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):42-50. PubMed ID: 11029267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 3',5'-dichloro-2,3,4-trihydroxy-2-methylbutylanilide (DTMBA) as a new potential biomarker of exposure to vinclozolin in urine.
    Cruz-Hurtado M; López-González ML; Escobar-Wilches DC; Sierra-Santoyo A
    Toxicol Appl Pharmacol; 2018 May; 346():1-8. PubMed ID: 29526525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and dosimetry of the antiandrogen vinclozolin after oral administration in the rat.
    Sierra-Santoyo A; Castañeda-Hernández G; Harrison RA; Barton HA; Hughes MF
    Toxicol Sci; 2008 Nov; 106(1):55-63. PubMed ID: 18703562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the "Enhanced OECD Test Guideline No. 407" to detect endocrine effects.
    Shin JH; Moon HJ; Kim TS; Kang IH; Ki HY; Choi KS; Han SY
    Arch Toxicol; 2006 Sep; 80(9):547-54. PubMed ID: 16489464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography determination of the anti-androgen vinclozolin and its metabolites in rat serum.
    Sierra-Santoyo A; Barton HA; Hughes MF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):105-10. PubMed ID: 15282099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo.
    Nellemann C; Dalgaard M; Lam HR; Vinggaard AM
    Toxicol Sci; 2003 Feb; 71(2):251-62. PubMed ID: 12563111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.